noun A type of cell that is capable of destroying neutrophils, which are a type of white blood cell involved in the immune response.
In the field of immunology, neutrophil-killers are studied for their potential role in modulating immune responses and treating conditions related to neutrophil dysfunction.
Neutrophil-killers are substances or medications that target and destroy neutrophils, a type of white blood cell involved in the immune response.
Pharmacologists investigate the mechanisms of action and potential side effects of neutrophil-killers in drug development and therapy.
Neutrophil-killers may be used in microbiology research to study interactions between pathogens and the immune system, particularly neutrophil responses.
In oncology, researchers explore the effects of neutrophil-killers on tumor microenvironments and their potential as adjuvant therapies in cancer treatment.
A doctor may use the term 'neutrophil-killer' when discussing treatments or medications that target and destroy neutrophils in the body, such as certain chemotherapy drugs used to treat cancer.
An immunologist may use the term 'neutrophil-killer' when studying the effects of various substances on neutrophils in the immune system, or when developing treatments that specifically target these cells.
A pharmacist may use the term 'neutrophil-killer' when dispensing medications that have the ability to reduce the number of neutrophils in the body, such as certain antibiotics or immunosuppressants.